Good things don't just come to those who wait. If you're wanting to get your startup in front of major corporations, you need to take matters into your own hands. Pexels

If you've ever wanted to know the best way to get your startup in front of a major corporation, according to experts from both sides of the table — here's your chance.

At the Houston Innovation Open Conference, five major players in Houston's innovation ecosystem sat on a panel and discussed startups, accelerators, and more. One question asked each panelist for their advice for corporate partnerships. Here's what they had to say.

“Go to one of our programs — even if you used to work at an oil and gas company, as a startup, you need new pathways and you need help and support and lots of love along the way.”

Gabriella Rowe, CEO of Station Houston. Even with a Houston business background, there's strength in numbers, she says.

“Keep your identity along the way.”

Haibin Xu, regional manager of Shell Research Connect & GameChanger US and Canada. From the corporate side of things. Xu said sometimes the Shells of the world can't help you — find the right company that best aligns with your startup.

“Do your research. … And have a clear value proposition, and put it on the table.”

Wade Bitaraf, head of energy and sustainability practice at Plug and Play. Preparation and research is extremely important before you meet with any potential corporate partners.

“Find a community to join … and don’t limit yourself to what you think is your industry.”

Brad True, managing director of The Cannon and Cannon Ventures. True gave an example of a Cannon company that found success outside the industry they thought they were confined to.

“You have to find the pathways that are going to make it as easy as possible.”

Brian Richards, innovation lead and managing director at Accenture. Richards emphasized that startups can go bankrupt waiting for something formal from a big corporation.

Speakers at the third annual Houston Innovation Open Conference discussed policy, performance, and more. Photo by Zview/Getty Images

Overheard: 5 powerful quotes from Houstonians speaking at the Houston Open Innovation Conference

EAVESDROPPING IN Houston

When it comes to Houston's innovation ecosystem, there's a lot to discuss. From accelerator programs to role of educational institutes, the third annual Houston Open Innovation Conference covered it all on Thursday, March 28.

I had the pleasure of attending the full-day conference, which was a meeting of the minds of Houston innovation. To catch you up and rid you of your fear of missing out, check out these five overheard quotes from the day.

“I’ve charged my board on Houston Exponential, and I say to them, ‘What good is it for us to be the most diverse city in the country if we’re not solving the challenges that impact diverse communities.’”

Amanda Edwards, Houston City Council Member in At-Large Position 4, in her keynote presentation calling for Houston to lead the charge in solving inequalities in innovation.

“Competition is good. I would rather have an abundance of an ecosystem than just one (accelerator). I think each different group — whether it’s MassChallenge, Station Houston, or The Cannon or any other current or future accelerator — all has their own value proposition.”

Brian Richards, managing director, Accenture Houston Innovation Hub, during the panel about startups and entrepreneurs. The quote was in response to an audience question about competition within Houston accelerators and programs.

“If we don’t create this ecosystem, others will tap into the resources we have, and we lose or we fall short.”

Mayor Sylvester Turner, in his keynote presentation, explaining why the city is focused on developing the city's ecosystem now — before it's too late.

“I think the more emphasis on incubators and accelerators has addressed the need for community. You have people who are like minded … and you have a community that cares about something more deep rather than just being in the same physical space together.”

Grace Rodriguez, CEO and executive director of Impact Hub Houston, on the panel about accelerators and incubators. The panel question was regarding how some coworking spaces have evolved to be accelerator or incubator programs.

“This is such a uniquely positioned city because of its corporate base, because of the strength of its university structure, and because of the combination of that and the ability to collaborate within those two is a different kind of runway or opportunity.”

Susan Davenport, senior vice president, economic development at the Greater Houston Partnership, during the "Houston Innovation Ecosystem" panel.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston engineers develop breakthrough device to advance spinal cord treatment

future of health

A team of Rice University engineers has developed an implantable probe over a hundred times smaller than the width of a hair that aims to help develop better treatments for spinal cord disease and injury.

Detailed in a recent study published in Cell Reports, the probe or sensor, known as spinalNET, is used to explore how neurons in the spinal cord process sensation and control movement, according to a statement from Rice. The research was supported by the National Institutes of Health, Rice, the California-based Salk Institute for Biological Studies, and the philanthropic Mary K. Chapman Foundation based in Oklahoma.

The soft and flexible sensor was used to record neuronal activity in freely moving mice with high resolution for multiple days. Historically, tracking this level of activity has been difficult for researchers because the spinal cord and its neurons move so much during normal activity, according to the team.

“We developed a tiny sensor, spinalNET, that records the electrical activity of spinal neurons as the subject performs normal activity without any restraint,” Yu Wu, a research scientist at Rice and lead author of the study said in a statement. “Being able to extract such knowledge is a first but important step to develop cures for millions of people suffering from spinal cord diseases.”

The team says that before now the spinal cord has been considered a "black box." But the device has already helped the team uncover new findings about the body's rhythmic motor patterns, which drive walking, breathing and chewing.

Lan Luan (from left), Yu Wu, and Chong Xie are working on the breakthrough device. Photo by Jeff Fitlow/Rice University

"Some (spinal neurons) are strongly correlated with leg movement, but surprisingly, a lot of neurons have no obvious correlation with movement,” Wu said in the statement. “This indicates that the spinal circuit controlling rhythmic movement is more complicated than we thought.”

The team said they hope to explore these findings further and aim to use the technology for additional medical purposes.

“In addition to scientific insight, we believe that as the technology evolves, it has great potential as a medical device for people with spinal cord neurological disorders and injury,” Lan Luan, an associate professor of electrical and computer engineering at Rice and a corresponding author on the study, added in the statement.

Rice researchers have developed several implantable, minimally invasive devices to address health and mental health issues.

In the spring, the university announced that the United States Department of Defense had awarded a four-year, $7.8 million grant to the Texas Heart Institute and a Rice team led by co-investigator Yaxin Wang to continue to break ground on a novel left ventricular assist device (LVAD) that could be an alternative to current devices that prevent heart transplantation.

That same month, the university shared news that Professor Jacob Robinson had published findings on minimally invasive bioelectronics for treating psychiatric conditions. The 9-millimeter device can deliver precise and programmable stimulation to the brain to help treat depression, obsessive-compulsive disorder and post-traumatic stress disorder.

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.